June 23rd 2025
Matthew Stober and Campbell Bunce of Abzena talk about the CDMO’s role in accelerating the path of newer and more effective modalities to market.
Cell Culture Optimization—Part Two
December 23rd 2024Bob Schrock, PhD, senior director, global head of Process Development, at Lonza provides insight on how process controls change during development through commercialization, how cell harvesting can be optimized, and which validation and/or qualification studies are performed for cell culture.
A Look at CDMO–Biotech Partnerships and Tackling Complex Technical Challenges (BIO 2024)
October 30th 2024Frontage Laboratories' Marianna Tcherpakov, PhD, director of Business Development, CMC Services, discussed the CDMO’s role in enabling startup biotechs solve complex technical challenges for scale up.
Behind the Headlines: GLP-1 Shortage, Nobel Prize, RNA Editing, and More
October 24th 2024Laks Pernenkil, Brian Feth, and Alex Philippidis go behind the headlines to discuss the impact of recent news, including FDA’s drug shortage list update, Nobel prize winners in microRNA and AI, and a big-potential research win for RNA editing.